Vaccines reduce risk of long-COVID in breakthrough infections by 41%Non-vaccinated have much higher rates of persistent symptoms post infection Can school-aged children accurately self-collect nasal swabs for SARS-CoV-2 tests? Study compares results of nasal swabs for SARS-CoV-2 testing self-collected by children and adolescents with those collected by healthcare workers Interval of 6 months or more needed between rituximab treatment and COVID-19 vax Antibody response rates jumped from 17.3% to 66.7% with longer intervals. How effective are COVID-19 vaccines in preventing hospitalization? Large U.S. study compares hospitalization rates in unvaccinated, vaccinated and vaccinated plus booster dose individuals QUIZ: The latest on the flu shot As we head into fall and winter, it’s time to start thinking about influenza. Psychological distress may be a risk factor for post-COVID-19 conditions Depression, anxiety, worry, perceived stress or loneliness preceding SARS-CoV-2 infection may increase risk of developing “long” COVID symptoms. Extra dose of COVID vaccine beneficial to patients with hematologic cancers Improved SARS-CoV-2 antibody levels seen in most groups. New guidance: Should COVID vaccines and the flu shot be given together this fall? New FIP guidance highlights the benefits of giving flu shots and COVID-19 vaccines at the same time. Older adults with polypharmacy at risk of drug-drug interactions with nirmatrelvir-ritonavir Researchers propose a deprescribing strategy to mitigate risks. Pfizer COVID shots appear 73% effective in children under 5 Vaccinations for babies, toddlers and preschoolers opened in the U.S. in June after months of delay. First Previous 40 41 42 43 44 Next Last
